{"gene":"TUBB4A","run_date":"2026-04-28T21:43:00","timeline":{"discoveries":[{"year":2013,"finding":"A de novo missense mutation p.Asp249Asn in TUBB4A causes hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). Structural modeling showed the mutation sits at the intradimer interface of α-tubulin and β-tubulin, potentially affecting tubulin dimerization, microtubule polymerization, or microtubule stability.","method":"Exome sequencing of patient trios, structural modeling of αβ-tubulin heterodimer","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — identified in multiple independent families, structural modeling of mutation site, replicated across 11 patients","pmids":["23582646"],"is_preprint":false},{"year":2013,"finding":"A missense mutation p.Arg2Gly in TUBB4A causes DYT4 dystonia (whispering dysphonia). mRNA expression studies showed significantly reduced levels of mutant TUBB4A mRNA in heterozygous carriers, implicating abnormal microtubule function in the pathophysiology of dystonia.","method":"Genome-wide linkage analysis, genome sequencing, quantitative RT-PCR of TUBB4A mRNA levels in patient cells","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 2 — genetic mapping plus functional mRNA quantification, mutation confirmed in independent dystonia patients","pmids":["23595291"],"is_preprint":false},{"year":2017,"finding":"Different TUBB4A mutations cause mutation-specific cellular defects: the DYT4 mutation (p.Arg2Gly) alters neuronal morphology without changing tubulin quantity, polymerization, or oligodendrocyte morphology; mutations associated with hypomyelination (p.Val255Ile, p.Arg282Pro, p.Asn414Lys) alter oligodendrocyte morphology, myelin gene expression, and microtubule dynamics via a dominant toxic gain-of-function mechanism; the H-ABC mutation (p.Asp249Asn) causes overlapping neuronal and oligodendrocytic defects.","method":"Histopathological, biochemical (tubulin polymerization assays), and cellular approaches (neuronal and oligodendrocyte morphology, myelin gene expression) in patient-derived or mutation-expressing cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods, multiple mutations studied, clear mechanistic differentiation between neuronal and oligodendrocytic pathogenesis","pmids":["28973395"],"is_preprint":false},{"year":2017,"finding":"A point mutation in Tubb4a (p.Ala302Thr) in the taiep rat causes progressive microtubule accumulation specifically in oligodendrocytes (cell body and distal processes), leading to hypomyelination and demyelination; a similar oligodendrocyte microtubule accumulation was confirmed in a human patient with TUBB4A p.Asn414Lys mutation.","method":"Genetic mapping of taiep mutation to Tubb4a, light and electron microscopy of spinal cord and optic nerves, histological analysis of human patient cerebral white matter","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 2 — animal model with identified causal mutation confirmed by human patient pathology, direct cellular localization of microtubule accumulation","pmids":["28393430"],"is_preprint":false},{"year":2020,"finding":"A knock-in mouse model with the H-ABC mutation (p.Asp249Asn) in Tubb4a shows myelination deficits, dramatic loss of mature oligodendrocytes and oligodendrocyte progenitor cells, loss of cerebellar granular neurons and striatal neurons, and in vitro decreased neuronal survival with dysfunction in microtubule dynamics.","method":"Knock-in mouse model (heterozygous and homozygous), in vivo behavioral assays, immunohistochemistry for oligodendrocyte markers, in vitro microtubule dynamics assays in neurons","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model with multiple cellular and molecular readouts, microtubule dynamics directly measured","pmids":["32463361"],"is_preprint":false},{"year":2022,"finding":"TUBB4A interacts with MYH9 (non-muscle myosin IIA) during constricted cell migration to protect the nucleus from DNA damage. TUBB4A/GSK3β binds the N-terminal region of MYH9; TUBB4A KO reduces MYH9-mediated GSK3β ubiquitination and degradation, thereby decreasing β-catenin signaling and epithelial-mesenchymal transition. TUBB4A KO in prostate cancer cells reduces cell growth and migration and induces DNA damage (increased γH2AX and 53BP1).","method":"Co-immunoprecipitation, TUBB4A knockout in prostate cancer cell lines, γH2AX/53BP1 immunostaining, ubiquitination assays, prostate-specific Tubb4a conditional knockout mouse model with tumor growth and metastasis readouts","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, KO cell lines with multiple phenotypic readouts, in vivo mouse model confirmation","pmids":["35589707"],"is_preprint":false},{"year":1986,"finding":"The chicken beta 5-tubulin gene (ortholog of TUBB4A) encodes a highly divergent beta-tubulin isotype expressed broadly across cell and tissue types but notably absent from neurons, whereas the related c-beta 4 gene is expressed exclusively in neuronal cells, revealing complementary expression patterns suggesting a functional requirement for divergent beta-tubulin isotypes in all cell types.","method":"Gene sequencing, Northern blot analysis across tissues and cell types","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct expression analysis by Northern blot, ortholog in chicken; mechanistic inference from expression pattern","pmids":["3025656"],"is_preprint":false},{"year":2019,"finding":"TUBB4 (TUBB4A) interacts with GLUT1 (glucose transporter 1) in glioblastoma cells; this interaction was identified by mass spectrometry on human GBM specimens and confirmed by proximity ligation assay and co-immunoprecipitation. Inhibition of TUBB4 with CR-42-24 reduces GLUT1 expression and reduces glioblastoma stem cell tumorsphere formation and self-renewal.","method":"Mass spectrometry on human GBM specimens, proximity ligation assay, co-immunoprecipitation, TUBB4 inhibitor treatment with functional readouts (tumorsphere formation, self-renewal)","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 3 — interaction confirmed by multiple methods but pharmacological inhibitor used rather than specific genetic KO of TUBB4A","pmids":["31491891"],"is_preprint":false},{"year":2014,"finding":"3D structural modeling of TUBB4A missense mutations reveals that mutation p.Glu410Lys directly impairs motor protein and/or microtubule-associated protein interactions with microtubules, while other H-ABC mutations affect longitudinal interactions for maintaining αβ-tubulin structure, suggesting distinct mechanisms of functional impairment.","method":"3D structural modeling of αβ-tubulin heterodimer with mapped mutations","journal":"Neurology","confidence":"Low","confidence_rationale":"Tier 4 — computational/structural modeling only, no direct in vitro validation of the proposed mechanisms in this paper","pmids":["24850488"],"is_preprint":false}],"current_model":"TUBB4A encodes a neuronally expressed β-tubulin isotype that is an essential component of microtubules in neurons and oligodendrocytes; disease-causing mutations cause mutation-specific defects including altered microtubule polymerization/dynamics and toxic microtubule accumulation in oligodendrocytes (hypomyelination phenotypes) or altered neuronal morphology without microtubule dysfunction (dystonia phenotype), while in cancer cells TUBB4A interacts with MYH9 to protect the nucleus during constricted migration and sustains β-catenin signaling via regulation of GSK3β ubiquitination."},"narrative":{"teleology":[{"year":1986,"claim":"Establishing that divergent β-tubulin isotypes have tissue-specific expression patterns revealed that functionally distinct tubulin genes serve different cell types, setting the stage for understanding isotype-specific roles.","evidence":"Northern blot expression analysis of chicken β-tubulin genes across tissues and cell types","pmids":["3025656"],"confidence":"Medium","gaps":["Chicken ortholog expression may not fully recapitulate mammalian TUBB4A tissue distribution","Expression pattern does not establish functional non-redundancy"]},{"year":2013,"claim":"Identification of TUBB4A as the causative gene for two distinct neurological diseases — H-ABC (p.Asp249Asn) and DYT4 dystonia (p.Arg2Gly) — established that this β-tubulin isotype is essential for normal brain development and myelination.","evidence":"Exome sequencing of H-ABC patient trios with structural modeling; genome-wide linkage and sequencing in DYT4 families with mRNA quantification","pmids":["23582646","23595291"],"confidence":"High","gaps":["Mechanism by which individual mutations cause disease was not yet experimentally resolved","Whether mutations affect tubulin folding, dimerization, or polymerization was inferred from modeling only"]},{"year":2014,"claim":"3D structural modeling predicted that different H-ABC mutations impair distinct aspects of tubulin function — some disrupting motor protein/MAP binding and others affecting longitudinal intradimer contacts — suggesting mutation-specific pathogenic mechanisms.","evidence":"Computational 3D structural modeling of αβ-tubulin heterodimer with mapped TUBB4A mutations","pmids":["24850488"],"confidence":"Low","gaps":["Predictions were purely computational with no biochemical or cell-biological validation","Whether motor protein binding is actually impaired by specific mutations was not tested","No in vitro reconstitution of mutant microtubules"]},{"year":2017,"claim":"Systematic comparison of multiple TUBB4A mutations demonstrated that disease mutations cause cell-type-specific and mutation-specific defects: dystonia mutations alter neuronal morphology without disrupting microtubule dynamics, while hypomyelination mutations cause toxic microtubule accumulation in oligodendrocytes via a dominant gain-of-function mechanism.","evidence":"Tubulin polymerization assays, neuronal and oligodendrocyte morphology analysis, myelin gene expression; taiep rat model with Tubb4a p.Ala302Thr confirmed by electron microscopy and human patient histology","pmids":["28973395","28393430"],"confidence":"High","gaps":["Why microtubules specifically accumulate in oligodendrocytes rather than other cell types is unexplained","The downstream signaling from microtubule accumulation to oligodendrocyte death is not defined"]},{"year":2019,"claim":"Discovery of a TUBB4A–GLUT1 interaction in glioblastoma cells raised the possibility that TUBB4A has roles beyond structural microtubule function, potentially in membrane protein trafficking or stabilization.","evidence":"Mass spectrometry on human GBM specimens, proximity ligation assay, co-immunoprecipitation, pharmacological inhibition of TUBB4 with functional readouts","pmids":["31491891"],"confidence":"Medium","gaps":["Pharmacological inhibitor CR-42-24 is not fully specific to TUBB4A; genetic KO confirmation is lacking","Whether TUBB4A directly binds GLUT1 or the interaction is microtubule-mediated is unclear"]},{"year":2020,"claim":"A knock-in mouse model of the H-ABC mutation directly demonstrated that p.Asp249Asn causes myelination deficits, loss of oligodendrocytes and their progenitors, neuronal loss, and impaired microtubule dynamics, providing in vivo validation of the pathogenic mechanism.","evidence":"Heterozygous and homozygous Tubb4a knock-in mice with behavioral, immunohistochemical, and in vitro microtubule dynamics assays","pmids":["32463361"],"confidence":"High","gaps":["Whether oligodendrocyte loss is cell-autonomous or secondary to neuronal pathology is not fully resolved","Therapeutic rescue strategies have not been tested in this model"]},{"year":2022,"claim":"Beyond its structural role, TUBB4A was shown to interact with MYH9 during confined cell migration to protect the nucleus from DNA damage and to regulate β-catenin signaling by promoting GSK3β ubiquitination, revealing a signaling axis relevant to cancer metastasis.","evidence":"Reciprocal co-IP, TUBB4A KO in prostate cancer cells, γH2AX/53BP1 staining, ubiquitination assays, conditional Tubb4a KO mouse tumor model","pmids":["35589707"],"confidence":"High","gaps":["Whether the MYH9–TUBB4A interaction is direct or requires other adaptor proteins is not fully defined","Relevance of this cancer signaling axis to non-cancer contexts (neurons, oligodendrocytes) is unknown"]},{"year":null,"claim":"It remains unknown how TUBB4A mutations lead to selective vulnerability of oligodendrocytes versus neurons, what structural features distinguish TUBB4A from other β-tubulin isotypes functionally, and whether the MYH9/GSK3β signaling axis is active in the brain.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural or biochemical explanation for isotype-specific non-redundancy of TUBB4A","No defined mechanism linking microtubule accumulation to oligodendrocyte cell death","Whether the cancer-context signaling functions of TUBB4A are relevant to neurological disease is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,2,3,4]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,2,3,4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[2,3,4]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,1,2,3,4]}],"complexes":["αβ-tubulin heterodimer","microtubule"],"partners":["MYH9","GSK3B","TUBA1A","SLC2A1"],"other_free_text":[]},"mechanistic_narrative":"TUBB4A encodes a β-tubulin isotype that is a structural constituent of microtubules with critical roles in neurons and oligodendrocytes. Missense mutations in TUBB4A cause distinct neurological diseases depending on the affected residue: mutations at the intradimer interface (e.g., p.Asp249Asn) cause hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) through oligodendrocyte loss and disrupted microtubule dynamics, while the p.Arg2Gly mutation causes DYT4 dystonia with altered neuronal morphology but preserved microtubule polymerization [PMID:23582646, PMID:23595291, PMID:28973395, PMID:32463361]. Hypomyelination-associated mutations act through a dominant toxic gain-of-function mechanism that drives microtubule accumulation in oligodendrocytes, impairs myelin gene expression, and causes progressive demyelination [PMID:28973395, PMID:28393430]. In cancer cells, TUBB4A interacts with MYH9 to protect the nucleus during constricted migration and sustains β-catenin signaling by promoting GSK3β ubiquitination and degradation [PMID:35589707]."},"prefetch_data":{"uniprot":{"accession":"P04350","full_name":"Tubulin beta-4A chain","aliases":["Tubulin 5 beta","Tubulin beta-4 chain"],"length_aa":444,"mass_kda":49.6,"function":"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin","subcellular_location":"Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/P04350/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TUBB4A","classification":"Not Classified","n_dependent_lines":42,"n_total_lines":1208,"dependency_fraction":0.0347682119205298},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ARL2","stoichiometry":0.2},{"gene":"CCT6A","stoichiometry":0.2},{"gene":"RPS6KB1","stoichiometry":0.2},{"gene":"SAR1B","stoichiometry":0.2},{"gene":"TUBA1B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TUBB4A","total_profiled":1310},"omim":[{"mim_id":"612438","title":"LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6","url":"https://www.omim.org/entry/612438"},{"mim_id":"602662","title":"TUBULIN, BETA-4A; TUBB4A","url":"https://www.omim.org/entry/602662"},{"mim_id":"312080","title":"PELIZAEUS-MERZBACHER DISEASE; PMD","url":"https://www.omim.org/entry/312080"},{"mim_id":"128101","title":"DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4","url":"https://www.omim.org/entry/128101"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Microtubules","reliability":"Supported"},{"location":"Cytokinetic bridge","reliability":"Additional"},{"location":"Mitotic spindle","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"},{"location":"Primary cilium tip","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Flagellar centriole","reliability":"Additional"},{"location":"Principal piece","reliability":"Additional"},{"location":"End piece","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":1155.6}],"url":"https://www.proteinatlas.org/search/TUBB4A"},"hgnc":{"alias_symbol":["beta-5"],"prev_symbol":["TUBB4","DYT4"]},"alphafold":{"accession":"P04350","domains":[{"cath_id":"3.40.50.1440","chopping":"2-265","consensus_level":"medium","plddt":93.8859,"start":2,"end":265},{"cath_id":"3.30.1330.20","chopping":"268-373","consensus_level":"medium","plddt":92.2632,"start":268,"end":373},{"cath_id":"1.10.287.600","chopping":"376-441","consensus_level":"medium","plddt":87.4136,"start":376,"end":441}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P04350","model_url":"https://alphafold.ebi.ac.uk/files/AF-P04350-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P04350-F1-predicted_aligned_error_v6.png","plddt_mean":92.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TUBB4A","jax_strain_url":"https://www.jax.org/strain/search?query=TUBB4A"},"sequence":{"accession":"P04350","fasta_url":"https://rest.uniprot.org/uniprotkb/P04350.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P04350/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P04350"}},"corpus_meta":[{"pmid":"8477447","id":"PMC_8477447","title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8477447","citation_count":1899,"is_preprint":false},{"pmid":"12235007","id":"PMC_12235007","title":"Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12235007","citation_count":495,"is_preprint":false},{"pmid":"8790405","id":"PMC_8790405","title":"Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8790405","citation_count":406,"is_preprint":false},{"pmid":"7523420","id":"PMC_7523420","title":"Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7523420","citation_count":355,"is_preprint":false},{"pmid":"1709170","id":"PMC_1709170","title":"Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1709170","citation_count":350,"is_preprint":false},{"pmid":"7537276","id":"PMC_7537276","title":"Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing.","date":"1995","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7537276","citation_count":302,"is_preprint":false},{"pmid":"7525598","id":"PMC_7525598","title":"Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7525598","citation_count":244,"is_preprint":false},{"pmid":"7592829","id":"PMC_7592829","title":"A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7592829","citation_count":233,"is_preprint":false},{"pmid":"1694173","id":"PMC_1694173","title":"Purification and functional characterization of integrin alpha v beta 5. An adhesion receptor for vitronectin.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1694173","citation_count":225,"is_preprint":false},{"pmid":"1825212","id":"PMC_1825212","title":"Polarized expression of integrin receptors (alpha 6 beta 4, alpha 2 beta 1, alpha 3 beta 1, and alpha v beta 5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1825212","citation_count":207,"is_preprint":false},{"pmid":"8794871","id":"PMC_8794871","title":"Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation.","date":"1996","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8794871","citation_count":182,"is_preprint":false},{"pmid":"7545239","id":"PMC_7545239","title":"Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway.","date":"1995","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7545239","citation_count":172,"is_preprint":false},{"pmid":"1918165","id":"PMC_1918165","title":"Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1918165","citation_count":172,"is_preprint":false},{"pmid":"2295601","id":"PMC_2295601","title":"Identification of a novel transforming growth factor-beta (TGF-beta 5) mRNA in Xenopus laevis.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2295601","citation_count":171,"is_preprint":false},{"pmid":"23582646","id":"PMC_23582646","title":"A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum.","date":"2013","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23582646","citation_count":164,"is_preprint":false},{"pmid":"11855984","id":"PMC_11855984","title":"Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins.","date":"2002","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11855984","citation_count":160,"is_preprint":false},{"pmid":"14739617","id":"PMC_14739617","title":"alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.","date":"2003","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/14739617","citation_count":159,"is_preprint":false},{"pmid":"31956038","id":"PMC_31956038","title":"Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis.","date":"2020","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/31956038","citation_count":154,"is_preprint":false},{"pmid":"7525179","id":"PMC_7525179","title":"Specific roles of the alpha V beta 1, alpha V beta 3 and alpha V beta 5 integrins in avian neural crest cell adhesion and migration on vitronectin.","date":"1994","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7525179","citation_count":152,"is_preprint":false},{"pmid":"9077549","id":"PMC_9077549","title":"Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9077549","citation_count":151,"is_preprint":false},{"pmid":"11457744","id":"PMC_11457744","title":"Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections.","date":"2001","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/11457744","citation_count":150,"is_preprint":false},{"pmid":"10995448","id":"PMC_10995448","title":"Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10995448","citation_count":133,"is_preprint":false},{"pmid":"7529872","id":"PMC_7529872","title":"Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7529872","citation_count":117,"is_preprint":false},{"pmid":"23595291","id":"PMC_23595291","title":"Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.","date":"2013","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23595291","citation_count":111,"is_preprint":false},{"pmid":"9154926","id":"PMC_9154926","title":"Bovine PAS-6/7 binds alpha v beta 5 integrins and anionic phospholipids through two domains.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9154926","citation_count":111,"is_preprint":false},{"pmid":"7510746","id":"PMC_7510746","title":"Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7510746","citation_count":105,"is_preprint":false},{"pmid":"7511640","id":"PMC_7511640","title":"B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7511640","citation_count":104,"is_preprint":false},{"pmid":"8631923","id":"PMC_8631923","title":"Integrin alpha v beta 5-dependent serine phosphorylation of paxillin in cultured human macrophages adherent to vitronectin.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8631923","citation_count":102,"is_preprint":false},{"pmid":"7689573","id":"PMC_7689573","title":"A study of the structure, function and distribution of beta 5 integrins using novel anti-beta 5 monoclonal antibodies.","date":"1993","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/7689573","citation_count":102,"is_preprint":false},{"pmid":"10964912","id":"PMC_10964912","title":"Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10964912","citation_count":94,"is_preprint":false},{"pmid":"7512969","id":"PMC_7512969","title":"Contrasting roles for integrin beta 1 and beta 5 cytoplasmic domains in subcellular localization, cell proliferation, and cell migration.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7512969","citation_count":94,"is_preprint":false},{"pmid":"12356872","id":"PMC_12356872","title":"P21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migration.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12356872","citation_count":91,"is_preprint":false},{"pmid":"2211615","id":"PMC_2211615","title":"cDNA sequence of the human integrin beta 5 subunit.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2211615","citation_count":87,"is_preprint":false},{"pmid":"8776358","id":"PMC_8776358","title":"Re-epithelialization of normal human excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6 integrins.","date":"1996","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/8776358","citation_count":86,"is_preprint":false},{"pmid":"7685013","id":"PMC_7685013","title":"The alpha v beta 5 integrin receptor regulates receptor-mediated endocytosis of vitronectin.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7685013","citation_count":85,"is_preprint":false},{"pmid":"7505746","id":"PMC_7505746","title":"Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes.","date":"1994","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/7505746","citation_count":85,"is_preprint":false},{"pmid":"12874035","id":"PMC_12874035","title":"Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12874035","citation_count":73,"is_preprint":false},{"pmid":"11162558","id":"PMC_11162558","title":"MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11162558","citation_count":72,"is_preprint":false},{"pmid":"7560092","id":"PMC_7560092","title":"Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5.","date":"1995","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/7560092","citation_count":72,"is_preprint":false},{"pmid":"28973395","id":"PMC_28973395","title":"TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28973395","citation_count":68,"is_preprint":false},{"pmid":"7523414","id":"PMC_7523414","title":"Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7523414","citation_count":67,"is_preprint":false},{"pmid":"35589707","id":"PMC_35589707","title":"TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35589707","citation_count":66,"is_preprint":false},{"pmid":"11152459","id":"PMC_11152459","title":"Nuclear localization of G protein beta 5 and regulator of G protein signaling 7 in neurons and brain.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11152459","citation_count":65,"is_preprint":false},{"pmid":"9239663","id":"PMC_9239663","title":"Integrins beta 5, beta 3 and alpha v are apically distributed in endometrial epithelium.","date":"1996","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/9239663","citation_count":64,"is_preprint":false},{"pmid":"8409379","id":"PMC_8409379","title":"Clonal deletion of V beta 5+ T cells by transgenic I-E restricted to thymic medullary epithelium.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8409379","citation_count":63,"is_preprint":false},{"pmid":"7510747","id":"PMC_7510747","title":"Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7510747","citation_count":62,"is_preprint":false},{"pmid":"3025656","id":"PMC_3025656","title":"Sequence and expression of the chicken beta 5- and beta 4-tubulin genes define a pair of divergent beta-tubulins with complementary patterns of expression.","date":"1986","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3025656","citation_count":59,"is_preprint":false},{"pmid":"9614556","id":"PMC_9614556","title":"The levels of integrin alpha v beta 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells.","date":"1998","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/9614556","citation_count":58,"is_preprint":false},{"pmid":"16882693","id":"PMC_16882693","title":"Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16882693","citation_count":57,"is_preprint":false},{"pmid":"19393042","id":"PMC_19393042","title":"Two-stage genome-wide association study identifies integrin beta 5 as having potential role in bull fertility.","date":"2009","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19393042","citation_count":56,"is_preprint":false},{"pmid":"21956287","id":"PMC_21956287","title":"Whispering dysphonia in an Australian family (DYT4): a clinical and genetic reappraisal.","date":"2011","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/21956287","citation_count":54,"is_preprint":false},{"pmid":"8120388","id":"PMC_8120388","title":"V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8120388","citation_count":53,"is_preprint":false},{"pmid":"11495924","id":"PMC_11495924","title":"RGS9-G beta 5 substrate selectivity in photoreceptors. Opposing effects of constituent domains yield high affinity of RGS interaction with the G protein-effector complex.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11495924","citation_count":53,"is_preprint":false},{"pmid":"28393430","id":"PMC_28393430","title":"A mutation in the Tubb4a gene leads to microtubule accumulation with hypomyelination and demyelination.","date":"2017","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28393430","citation_count":52,"is_preprint":false},{"pmid":"25085639","id":"PMC_25085639","title":"TUBB4A de novo mutations cause isolated hypomyelination.","date":"2014","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25085639","citation_count":52,"is_preprint":false},{"pmid":"1351503","id":"PMC_1351503","title":"Murine AIDS superantigen reactivity of the T cells bearing V beta 5 T cell antigen receptor.","date":"1992","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1351503","citation_count":51,"is_preprint":false},{"pmid":"402944","id":"PMC_402944","title":"Soluble and microsomal forms of NADH-cytochrome beta 5 reductase from human placenta. Similarity with NADH-methemoglobin reductase from human erythrocytes.","date":"1977","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/402944","citation_count":50,"is_preprint":false},{"pmid":"3426658","id":"PMC_3426658","title":"Cholestan-3 beta,5 alpha,6 beta-triol decreases barrier function of cultured endothelial cell monolayers.","date":"1987","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/3426658","citation_count":50,"is_preprint":false},{"pmid":"1967275","id":"PMC_1967275","title":"Expression of the V beta 5.1 gene by murine peripheral T cells is controlled by MHC genes and skewed to the CD8+ subset.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1967275","citation_count":48,"is_preprint":false},{"pmid":"1334117","id":"PMC_1334117","title":"Both intrathymic and peripheral selection modulate the differential expression of V beta 5 among CD4+ and CD8+ T cells.","date":"1992","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1334117","citation_count":48,"is_preprint":false},{"pmid":"24850488","id":"PMC_24850488","title":"Expanding the phenotypic spectrum of TUBB4A-associated hypomyelinating leukoencephalopathies.","date":"2014","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24850488","citation_count":46,"is_preprint":false},{"pmid":"7984276","id":"PMC_7984276","title":"A single point mutation increases the affinity of serotonin 5-HT1D alpha, 5-HT1D beta, 5-HT1E and 5-HT1F receptors for beta-adrenergic antagonists.","date":"1994","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/7984276","citation_count":46,"is_preprint":false},{"pmid":"12769841","id":"PMC_12769841","title":"Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12769841","citation_count":45,"is_preprint":false},{"pmid":"7556434","id":"PMC_7556434","title":"Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin.","date":"1995","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/7556434","citation_count":45,"is_preprint":false},{"pmid":"7543105","id":"PMC_7543105","title":"Alpha v beta 5 integrin receptor-mediated endocytosis of vitronectin is protein kinase C-dependent.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7543105","citation_count":45,"is_preprint":false},{"pmid":"25545912","id":"PMC_25545912","title":"H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?","date":"2014","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/25545912","citation_count":44,"is_preprint":false},{"pmid":"31491891","id":"PMC_31491891","title":"GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31491891","citation_count":42,"is_preprint":false},{"pmid":"20431064","id":"PMC_20431064","title":"Overexpression of integrin beta 5 enhances the paracrine properties of circulating angiogenic cells via Src kinase-mediated activation of STAT3.","date":"2010","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20431064","citation_count":41,"is_preprint":false},{"pmid":"19671851","id":"PMC_19671851","title":"Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).","date":"2009","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/19671851","citation_count":40,"is_preprint":false},{"pmid":"15721210","id":"PMC_15721210","title":"Cholesterol-3-beta, 5-alpha, 6-beta-triol induced genotoxicity through reactive oxygen species formation.","date":"2005","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/15721210","citation_count":39,"is_preprint":false},{"pmid":"7908916","id":"PMC_7908916","title":"The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7908916","citation_count":38,"is_preprint":false},{"pmid":"1317583","id":"PMC_1317583","title":"Divergent viral superantigens delete V beta 5+ T lymphocytes.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1317583","citation_count":38,"is_preprint":false},{"pmid":"24526230","id":"PMC_24526230","title":"Expansion of the spectrum of TUBB4A-related disorders: a new phenotype associated with a novel mutation in the TUBB4A gene.","date":"2014","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/24526230","citation_count":38,"is_preprint":false},{"pmid":"1714479","id":"PMC_1714479","title":"Conformational difference of T cell antigen receptors revealed by monoclonal antibodies to mouse V beta 5 T cell receptor for antigen determinants.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1714479","citation_count":37,"is_preprint":false},{"pmid":"20439458","id":"PMC_20439458","title":"Type IIB procollagen NH(2)-propeptide induces death of tumor cells via interaction with integrins alpha(V)beta(3) and alpha(V)beta(5).","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20439458","citation_count":37,"is_preprint":false},{"pmid":"8886177","id":"PMC_8886177","title":"Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney.","date":"1996","source":"American journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/8886177","citation_count":36,"is_preprint":false},{"pmid":"25772097","id":"PMC_25772097","title":"Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia.","date":"2015","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/25772097","citation_count":35,"is_preprint":false},{"pmid":"12670932","id":"PMC_12670932","title":"G beta 5.RGS7 inhibits G alpha q-mediated signaling via a direct protein-protein interaction.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12670932","citation_count":35,"is_preprint":false},{"pmid":"10579726","id":"PMC_10579726","title":"Enhancement of endothelial cell migration and in vitro tube formation by TAP20, a novel beta 5 integrin-modulating, PKC theta-dependent protein.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10579726","citation_count":35,"is_preprint":false},{"pmid":"3827976","id":"PMC_3827976","title":"Action of cholestane-3 beta,5 alpha,6 beta-triol on rats with particular reference to the aorta.","date":"1987","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/3827976","citation_count":34,"is_preprint":false},{"pmid":"24706558","id":"PMC_24706558","title":"Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24706558","citation_count":32,"is_preprint":false},{"pmid":"12551930","id":"PMC_12551930","title":"Ggamma subunit-selective G protein beta 5 mutant defines regulators of G protein signaling protein binding requirement for nuclear localization.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12551930","citation_count":31,"is_preprint":false},{"pmid":"8887293","id":"PMC_8887293","title":"Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates alpha v beta 5 integrin.","date":"1996","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/8887293","citation_count":30,"is_preprint":false},{"pmid":"10854285","id":"PMC_10854285","title":"Differential expression of the G protein beta(5) gene: analysis of mouse brain, peripheral tissues, and cultured cell lines.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10854285","citation_count":30,"is_preprint":false},{"pmid":"31882647","id":"PMC_31882647","title":"Up-regulated fibronectin in 3D culture facilitates spreading of triple negative breast cancer cells on 2D through integrin β-5 and Src.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31882647","citation_count":29,"is_preprint":false},{"pmid":"10985779","id":"PMC_10985779","title":"G protein beta 5 subunit interactions with alpha subunits and effectors.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10985779","citation_count":29,"is_preprint":false},{"pmid":"18433898","id":"PMC_18433898","title":"Biochemical roles of the oligosaccharide chains in thyrostimulin, a heterodimeric hormone of glycoprotein hormone subunits alpha 2 (GPA2) and beta 5 (GPB5).","date":"2008","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/18433898","citation_count":28,"is_preprint":false},{"pmid":"7682589","id":"PMC_7682589","title":"Preferential usage of T cell antigen receptor V region gene segment V beta 5.1 by Borrelia burgdorferi antigen-reactive T cell clones isolated from a patient with Lyme disease.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7682589","citation_count":28,"is_preprint":false},{"pmid":"9137089","id":"PMC_9137089","title":"Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells.","date":"1997","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9137089","citation_count":27,"is_preprint":false},{"pmid":"26643067","id":"PMC_26643067","title":"TUBB4A-related hypomyelinating leukodystrophy: New insights from a series of 12 patients.","date":"2015","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/26643067","citation_count":27,"is_preprint":false},{"pmid":"24742798","id":"PMC_24742798","title":"Clinical exome sequencing identifies a novel TUBB4A mutation in a child with static hypomyelinating leukodystrophy.","date":"2014","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24742798","citation_count":26,"is_preprint":false},{"pmid":"18090124","id":"PMC_18090124","title":"The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion.","date":"2007","source":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)","url":"https://pubmed.ncbi.nlm.nih.gov/18090124","citation_count":26,"is_preprint":false},{"pmid":"33999512","id":"PMC_33999512","title":"Cyr61 from adipose-derived stem cells promotes colorectal cancer metastasis and vasculogenic mimicry formation via integrin αV β5.","date":"2021","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33999512","citation_count":25,"is_preprint":false},{"pmid":"9658284","id":"PMC_9658284","title":"Concomitant expression of genes encoding integrin alpha v beta 5 heterodimer and vitronectin in growing parallel fibers of postnatal rat cerebellum: a possible role as mediators of parallel fiber elongation.","date":"1998","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9658284","citation_count":25,"is_preprint":false},{"pmid":"32463361","id":"PMC_32463361","title":"TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32463361","citation_count":24,"is_preprint":false},{"pmid":"33654384","id":"PMC_33654384","title":"Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin αvβ5 Signaling Pathway.","date":"2021","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33654384","citation_count":24,"is_preprint":false},{"pmid":"9367888","id":"PMC_9367888","title":"Efficient transfer of genes into senescent cells by adenovirus vectors via highly expressed alpha v beta 5 integrin.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9367888","citation_count":24,"is_preprint":false},{"pmid":"9683953","id":"PMC_9683953","title":"Distribution of integrins alpha v beta 5, alpha v beta 3 and alpha v in normal human cornea: possible implications in clinical and therapeutic adenoviral infection.","date":"1998","source":"Eye (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9683953","citation_count":24,"is_preprint":false},{"pmid":"9117344","id":"PMC_9117344","title":"Distinct structural requirements for interaction of the integrins alpha 5 beta 1, alpha v beta 5, and alpha v beta 6 with the central cell binding domain in fibronectin.","date":"1996","source":"Cell adhesion and communication","url":"https://pubmed.ncbi.nlm.nih.gov/9117344","citation_count":23,"is_preprint":false},{"pmid":"7551009","id":"PMC_7551009","title":"Integrin distribution in gastric carcinoma: association of beta 3 and beta 5 integrins with tumor invasiveness.","date":"1995","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/7551009","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50802,"output_tokens":2367,"usd":0.093955},"stage2":{"model":"claude-opus-4-6","input_tokens":5723,"output_tokens":2286,"usd":0.128647},"total_usd":0.222602,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"A de novo missense mutation p.Asp249Asn in TUBB4A causes hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). Structural modeling showed the mutation sits at the intradimer interface of α-tubulin and β-tubulin, potentially affecting tubulin dimerization, microtubule polymerization, or microtubule stability.\",\n      \"method\": \"Exome sequencing of patient trios, structural modeling of αβ-tubulin heterodimer\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — identified in multiple independent families, structural modeling of mutation site, replicated across 11 patients\",\n      \"pmids\": [\"23582646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A missense mutation p.Arg2Gly in TUBB4A causes DYT4 dystonia (whispering dysphonia). mRNA expression studies showed significantly reduced levels of mutant TUBB4A mRNA in heterozygous carriers, implicating abnormal microtubule function in the pathophysiology of dystonia.\",\n      \"method\": \"Genome-wide linkage analysis, genome sequencing, quantitative RT-PCR of TUBB4A mRNA levels in patient cells\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic mapping plus functional mRNA quantification, mutation confirmed in independent dystonia patients\",\n      \"pmids\": [\"23595291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Different TUBB4A mutations cause mutation-specific cellular defects: the DYT4 mutation (p.Arg2Gly) alters neuronal morphology without changing tubulin quantity, polymerization, or oligodendrocyte morphology; mutations associated with hypomyelination (p.Val255Ile, p.Arg282Pro, p.Asn414Lys) alter oligodendrocyte morphology, myelin gene expression, and microtubule dynamics via a dominant toxic gain-of-function mechanism; the H-ABC mutation (p.Asp249Asn) causes overlapping neuronal and oligodendrocytic defects.\",\n      \"method\": \"Histopathological, biochemical (tubulin polymerization assays), and cellular approaches (neuronal and oligodendrocyte morphology, myelin gene expression) in patient-derived or mutation-expressing cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods, multiple mutations studied, clear mechanistic differentiation between neuronal and oligodendrocytic pathogenesis\",\n      \"pmids\": [\"28973395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A point mutation in Tubb4a (p.Ala302Thr) in the taiep rat causes progressive microtubule accumulation specifically in oligodendrocytes (cell body and distal processes), leading to hypomyelination and demyelination; a similar oligodendrocyte microtubule accumulation was confirmed in a human patient with TUBB4A p.Asn414Lys mutation.\",\n      \"method\": \"Genetic mapping of taiep mutation to Tubb4a, light and electron microscopy of spinal cord and optic nerves, histological analysis of human patient cerebral white matter\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — animal model with identified causal mutation confirmed by human patient pathology, direct cellular localization of microtubule accumulation\",\n      \"pmids\": [\"28393430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A knock-in mouse model with the H-ABC mutation (p.Asp249Asn) in Tubb4a shows myelination deficits, dramatic loss of mature oligodendrocytes and oligodendrocyte progenitor cells, loss of cerebellar granular neurons and striatal neurons, and in vitro decreased neuronal survival with dysfunction in microtubule dynamics.\",\n      \"method\": \"Knock-in mouse model (heterozygous and homozygous), in vivo behavioral assays, immunohistochemistry for oligodendrocyte markers, in vitro microtubule dynamics assays in neurons\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with multiple cellular and molecular readouts, microtubule dynamics directly measured\",\n      \"pmids\": [\"32463361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TUBB4A interacts with MYH9 (non-muscle myosin IIA) during constricted cell migration to protect the nucleus from DNA damage. TUBB4A/GSK3β binds the N-terminal region of MYH9; TUBB4A KO reduces MYH9-mediated GSK3β ubiquitination and degradation, thereby decreasing β-catenin signaling and epithelial-mesenchymal transition. TUBB4A KO in prostate cancer cells reduces cell growth and migration and induces DNA damage (increased γH2AX and 53BP1).\",\n      \"method\": \"Co-immunoprecipitation, TUBB4A knockout in prostate cancer cell lines, γH2AX/53BP1 immunostaining, ubiquitination assays, prostate-specific Tubb4a conditional knockout mouse model with tumor growth and metastasis readouts\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, KO cell lines with multiple phenotypic readouts, in vivo mouse model confirmation\",\n      \"pmids\": [\"35589707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"The chicken beta 5-tubulin gene (ortholog of TUBB4A) encodes a highly divergent beta-tubulin isotype expressed broadly across cell and tissue types but notably absent from neurons, whereas the related c-beta 4 gene is expressed exclusively in neuronal cells, revealing complementary expression patterns suggesting a functional requirement for divergent beta-tubulin isotypes in all cell types.\",\n      \"method\": \"Gene sequencing, Northern blot analysis across tissues and cell types\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct expression analysis by Northern blot, ortholog in chicken; mechanistic inference from expression pattern\",\n      \"pmids\": [\"3025656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TUBB4 (TUBB4A) interacts with GLUT1 (glucose transporter 1) in glioblastoma cells; this interaction was identified by mass spectrometry on human GBM specimens and confirmed by proximity ligation assay and co-immunoprecipitation. Inhibition of TUBB4 with CR-42-24 reduces GLUT1 expression and reduces glioblastoma stem cell tumorsphere formation and self-renewal.\",\n      \"method\": \"Mass spectrometry on human GBM specimens, proximity ligation assay, co-immunoprecipitation, TUBB4 inhibitor treatment with functional readouts (tumorsphere formation, self-renewal)\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — interaction confirmed by multiple methods but pharmacological inhibitor used rather than specific genetic KO of TUBB4A\",\n      \"pmids\": [\"31491891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"3D structural modeling of TUBB4A missense mutations reveals that mutation p.Glu410Lys directly impairs motor protein and/or microtubule-associated protein interactions with microtubules, while other H-ABC mutations affect longitudinal interactions for maintaining αβ-tubulin structure, suggesting distinct mechanisms of functional impairment.\",\n      \"method\": \"3D structural modeling of αβ-tubulin heterodimer with mapped mutations\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/structural modeling only, no direct in vitro validation of the proposed mechanisms in this paper\",\n      \"pmids\": [\"24850488\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TUBB4A encodes a neuronally expressed β-tubulin isotype that is an essential component of microtubules in neurons and oligodendrocytes; disease-causing mutations cause mutation-specific defects including altered microtubule polymerization/dynamics and toxic microtubule accumulation in oligodendrocytes (hypomyelination phenotypes) or altered neuronal morphology without microtubule dysfunction (dystonia phenotype), while in cancer cells TUBB4A interacts with MYH9 to protect the nucleus during constricted migration and sustains β-catenin signaling via regulation of GSK3β ubiquitination.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TUBB4A encodes a β-tubulin isotype that is a structural constituent of microtubules with critical roles in neurons and oligodendrocytes. Missense mutations in TUBB4A cause distinct neurological diseases depending on the affected residue: mutations at the intradimer interface (e.g., p.Asp249Asn) cause hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) through oligodendrocyte loss and disrupted microtubule dynamics, while the p.Arg2Gly mutation causes DYT4 dystonia with altered neuronal morphology but preserved microtubule polymerization [PMID:23582646, PMID:23595291, PMID:28973395, PMID:32463361]. Hypomyelination-associated mutations act through a dominant toxic gain-of-function mechanism that drives microtubule accumulation in oligodendrocytes, impairs myelin gene expression, and causes progressive demyelination [PMID:28973395, PMID:28393430]. In cancer cells, TUBB4A interacts with MYH9 to protect the nucleus during constricted migration and sustains β-catenin signaling by promoting GSK3β ubiquitination and degradation [PMID:35589707].\",\n  \"teleology\": [\n    {\n      \"year\": 1986,\n      \"claim\": \"Establishing that divergent β-tubulin isotypes have tissue-specific expression patterns revealed that functionally distinct tubulin genes serve different cell types, setting the stage for understanding isotype-specific roles.\",\n      \"evidence\": \"Northern blot expression analysis of chicken β-tubulin genes across tissues and cell types\",\n      \"pmids\": [\"3025656\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Chicken ortholog expression may not fully recapitulate mammalian TUBB4A tissue distribution\",\n        \"Expression pattern does not establish functional non-redundancy\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of TUBB4A as the causative gene for two distinct neurological diseases — H-ABC (p.Asp249Asn) and DYT4 dystonia (p.Arg2Gly) — established that this β-tubulin isotype is essential for normal brain development and myelination.\",\n      \"evidence\": \"Exome sequencing of H-ABC patient trios with structural modeling; genome-wide linkage and sequencing in DYT4 families with mRNA quantification\",\n      \"pmids\": [\"23582646\", \"23595291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which individual mutations cause disease was not yet experimentally resolved\",\n        \"Whether mutations affect tubulin folding, dimerization, or polymerization was inferred from modeling only\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"3D structural modeling predicted that different H-ABC mutations impair distinct aspects of tubulin function — some disrupting motor protein/MAP binding and others affecting longitudinal intradimer contacts — suggesting mutation-specific pathogenic mechanisms.\",\n      \"evidence\": \"Computational 3D structural modeling of αβ-tubulin heterodimer with mapped TUBB4A mutations\",\n      \"pmids\": [\"24850488\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Predictions were purely computational with no biochemical or cell-biological validation\",\n        \"Whether motor protein binding is actually impaired by specific mutations was not tested\",\n        \"No in vitro reconstitution of mutant microtubules\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Systematic comparison of multiple TUBB4A mutations demonstrated that disease mutations cause cell-type-specific and mutation-specific defects: dystonia mutations alter neuronal morphology without disrupting microtubule dynamics, while hypomyelination mutations cause toxic microtubule accumulation in oligodendrocytes via a dominant gain-of-function mechanism.\",\n      \"evidence\": \"Tubulin polymerization assays, neuronal and oligodendrocyte morphology analysis, myelin gene expression; taiep rat model with Tubb4a p.Ala302Thr confirmed by electron microscopy and human patient histology\",\n      \"pmids\": [\"28973395\", \"28393430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Why microtubules specifically accumulate in oligodendrocytes rather than other cell types is unexplained\",\n        \"The downstream signaling from microtubule accumulation to oligodendrocyte death is not defined\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery of a TUBB4A–GLUT1 interaction in glioblastoma cells raised the possibility that TUBB4A has roles beyond structural microtubule function, potentially in membrane protein trafficking or stabilization.\",\n      \"evidence\": \"Mass spectrometry on human GBM specimens, proximity ligation assay, co-immunoprecipitation, pharmacological inhibition of TUBB4 with functional readouts\",\n      \"pmids\": [\"31491891\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Pharmacological inhibitor CR-42-24 is not fully specific to TUBB4A; genetic KO confirmation is lacking\",\n        \"Whether TUBB4A directly binds GLUT1 or the interaction is microtubule-mediated is unclear\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A knock-in mouse model of the H-ABC mutation directly demonstrated that p.Asp249Asn causes myelination deficits, loss of oligodendrocytes and their progenitors, neuronal loss, and impaired microtubule dynamics, providing in vivo validation of the pathogenic mechanism.\",\n      \"evidence\": \"Heterozygous and homozygous Tubb4a knock-in mice with behavioral, immunohistochemical, and in vitro microtubule dynamics assays\",\n      \"pmids\": [\"32463361\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether oligodendrocyte loss is cell-autonomous or secondary to neuronal pathology is not fully resolved\",\n        \"Therapeutic rescue strategies have not been tested in this model\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Beyond its structural role, TUBB4A was shown to interact with MYH9 during confined cell migration to protect the nucleus from DNA damage and to regulate β-catenin signaling by promoting GSK3β ubiquitination, revealing a signaling axis relevant to cancer metastasis.\",\n      \"evidence\": \"Reciprocal co-IP, TUBB4A KO in prostate cancer cells, γH2AX/53BP1 staining, ubiquitination assays, conditional Tubb4a KO mouse tumor model\",\n      \"pmids\": [\"35589707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the MYH9–TUBB4A interaction is direct or requires other adaptor proteins is not fully defined\",\n        \"Relevance of this cancer signaling axis to non-cancer contexts (neurons, oligodendrocytes) is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how TUBB4A mutations lead to selective vulnerability of oligodendrocytes versus neurons, what structural features distinguish TUBB4A from other β-tubulin isotypes functionally, and whether the MYH9/GSK3β signaling axis is active in the brain.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural or biochemical explanation for isotype-specific non-redundancy of TUBB4A\",\n        \"No defined mechanism linking microtubule accumulation to oligodendrocyte cell death\",\n        \"Whether the cancer-context signaling functions of TUBB4A are relevant to neurological disease is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2, 3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 2, 3, 4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [2, 3, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4]}\n    ],\n    \"complexes\": [\n      \"αβ-tubulin heterodimer\",\n      \"microtubule\"\n    ],\n    \"partners\": [\n      \"MYH9\",\n      \"GSK3B\",\n      \"TUBA1A\",\n      \"SLC2A1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}